EU panel recommends Ionis olezarsen for severe hypertriglyceridemia
Ionis Pharmaceuticals (Nasdaq: IONS) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

